Researchers present ten cutting-edge anti-aging strategies—from cellular reprogramming and senolytics to AI-driven drug discovery—explaining mechanisms and therapeutic aims across models and interventions.
Key points
- Partial in vivo reprogramming with Yamanaka factors restores tissue function and extends lifespan in mice.
- Senolytic cocktail dasatinib + quercetin reduces inflammation and improves joint function in osteoarthritis patients.
- AI-driven screening by Insilico Medicine identifies novel senolytic compounds in under two years.
Why it matters: These breakthroughs collectively offer scalable, mechanism-based strategies for reversing cellular aging and extending human healthspan beyond existing symptomatic treatments.
Q&A
- What are Yamanaka factors?
- How do senolytics work?
- What is an epigenetic clock?
- Why target NAD+ levels?
- What role does AI play in longevity research?